Chromatin Regulator SPEN/SHARP in X Inactivation and Disease
Autor: | Giaimo, Benedetto Daniele, Robert-Finestra, Teresa, Oswald, Franz, Gribnau, Joost, Borggrefe, Tilman |
---|---|
Rok vydání: | 2021 |
Předmět: |
SHARP
DNA methylation Review X-Chromosom lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens lcsh:RC254-282 XCI HDAC Polycomb-Gruppe silencing Polycomb-group proteins Spen NCoR ddc:610 Histon-Deacetylase DNS-Methyltransferase transcription repression X chromosome inactivation DDC 610 / Medicine & health polycomb |
Zdroj: | Cancers, Vol 13, Iss 1665, p 1665 (2021) Cancers |
ISSN: | 2072-6694 |
Popis: | Enzymes, such as histone methyltransferases and demethylases, histone acetyltransferases and deacetylases, and DNA methyltransferases are known as epigenetic modifiers that are often implicated in tumorigenesis and disease. One of the best-studied chromatin-based mechanism is X chromosome inactivation (XCI), a process that establishes facultative heterochromatin on only one X chromosome in females and establishes the right dosage of gene expression. The specificity factor for this process is the long non-coding RNA Xinactivespecifictranscript (Xist), which is upregulated from one X chromosome in female cells. Subsequently, Xist is bound by the corepressor SHARP/SPEN, recruiting and/or activating histone deacetylases (HDACs), leading to the loss of active chromatin marks such as H3K27ac. In addition, polycomb complexes PRC1 and PRC2 establish wide-spread accumulation of H3K27me3 and H2AK119ub1 chromatin marks. The lack of active marks and establishment of repressive marks set the stage for DNA methyltransferases (DNMTs) to stably silence the X chromosome. Here, we will review the recent advances in understanding the molecular mechanisms of how heterochromatin formation is established and put this into the context of carcinogenesis and disease. publishedVersion |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |